Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Français (Suisse)
Italiano
Nederlands (Nederland)
Nederlands (België)
Markets
Equities
North America
Europe
Asia
Oceania
Middle East
»
More Equities
Indexes
S&P 500
DOW JONES
NASDAQ 100
EURO STOXX 50
NIKKEI 225
»
More Indexes
Currency / Forex
USD / EUR
USD / CAD
USD / MXN
USD / BRL
USD / INR
»
More Currencies
Commodities
GOLD
Crude Oil (WTI)
Crude Oil (BRENT)
SILVER
PLATINUM
»
More Commodities
Trackers & ETF
Rankings and News
Advanced Search
Cryptocurrencies
BITCOIN
ETHEREUM
News
Latest News
Companies
Markets
Economy
Currency / Forex
Commodities
Interest Rates
Business Leaders
Cryptocurrencies
Cybersecurity
Economic Calendar
Listed companies
Analyst Reco.
Rumors
IPOs
Capital Markets Transactions
New Contracts
Profit Warnings
Appointments
Press Releases
Events
Security Transactions
Financial Calendar
Sector News
Energy
Basic Materials
Industrials
Consumer Cyclical
Consumer Non-Cyclical
Financials
Healthcare
Technology
Telecommunications Services
Utilities
Analysis
All Analysis
Must Read
Daily Briefing
Weekly market update
Stock Trading Strategies
Stock Picks
All Stock Picks
Subscribe
Portfolios
My Portfolio
Virtual Portfolios
MarketScreener Portfolios
USA Portfolio
European Portfolio
Asian Portfolio
Watchlists
My Watchlists
Watchlists
My previous session
My most visited
Most popular
Investment Style
ESG stocks
Trend-Following Stocks
Undervalued stocks
Growth stocks
Yield stocks
Multibaggers
Investment Themes
Robotics
Defense
Hydrogen
Oligopolies
Let’s all cycle!
Millennials
Rankings
Top News
Most Read News
Hot News
Top Fundamentals
Top Capitalization
Top Yield
Top PER
Top Consensus
Top Fundamentals
Top ranking ESG
Top Technicals
Top RSI
Unusual volumes
Top Gaps
Top STIM
Breakouts
Trends
Top Movers
Top USA
Top Canada
Top U.K.
Top Germany
Top Europe
Top Asia
Screeners
Investment Themes
Robotics
Defense
Hydrogen
Oligopolies
Let’s all cycle!
Millennials
Technical Rankings
Oversold stocks
Overbought stocks
Close to resistance
Close to support
Accumulation Phases
Most volatile stocks
Fundamental Rankings
Top Investor Rating
Top Trading Rating
Top Consensus
Growth stocks
Yield stocks
Low valuations
Stock Screener Home
My Screeners
All my stocks
Watchlists
Virtual Portfolios
Tools
MarketScreener tools
Stock Screener
iPhone App
Expert tools
Stock Screener PRO
Portfolio Creator
Event Screener
Dynamic Chart
Financial Calendar
Economic Calendar
Apprendre la bourse
ProRealTime Trading
Our Services
MarketScreener Portfolios
European Portfolio
USA Portfolio
Asian Portfolio
Our Stock Picks
Thematic Investment Lists
Stock Screener
Homepage
Equities
United States
Nasdaq
Moderna, Inc.
News
Summary
MRNA
US60770K1079
MODERNA, INC.
(MRNA)
Add to my list
Report
Delayed Nasdaq -
05/16 04:00:00 pm EDT
136.26
USD
-1.20%
05/13
MODERNA, INC. Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K/A)
AQ
05/13
SECTOR UPDATE
: Health Care Stocks Gain Premarket Friday
MT
05/13
KHF Welcomes the African Medicines Agency Treaty Cabinet Approval
AQ
Summary
Quotes
Charts
News
Ratings
Calendar
Company
Financials
Consensus
Revisions
Summary
Most relevant
All News
Analyst Reco.
Other languages
Press Releases
Official Publications
Sector news
MarketScreener Strategies
Most relevant news about MODERNA, INC.
05/13
KHF Welcomes the African Medicines Agency Treaty Cabinet Approval
AQ
05/13
Swiss Medical Regulator Approves Moderna's Covid-19 Vaccine for 6-11-Year-Olds
MT
05/13
Swissmedic OKs Moderna's COVID-19 Jab For Children Aged Six To 11 Years
MT
05/13
Switzerland authorizes Moderna's COVID vaccine for 6-11 year olds
RE
05/12
Moderna CFO exits firm a day after taking charge as probe launched
AQ
05/11
Moderna completes FDA submission for use of COVID shot in adolescents, kids
RE
05/11
Moderna, Inc. Fires Jorge Gomez as CFO
CI
05/11
Moderna Says Recently Named CFO Jorge Gomez Departs; David Meline Continues as CFO
MT
05/11
Moderna CFO, Jorge Gomez, Resigns Effective Immediately
MT
05/11
Moderna CFO exits a day after taking charge as former employer launches probe
RE
05/11
Moderna's new CFO Jorge Gomez steps down
RE
05/10
What you need to know about the coronavirus right now
RE
05/05
U.S. limits use of J&J's COVID vaccine on blood clot risks
RE
05/05
Moderna rides high on Covid-19 vaccine sales with $6bn revenue
AQ
05/04
INSIDER SELL
: Moderna
MT
More most relevant news
All news about MODERNA, INC.
05/13
MODERNA, INC. Change in Directors or Principal Officers, Financial Statements and Exhi..
AQ
05/13
SECTOR UPDATE
: Health Care Stocks Gain Premarket Friday
MT
05/13
KHF Welcomes the African Medicines Agency Treaty Cabinet Approval
AQ
05/13
Swiss Medical Regulator Approves Moderna's Covid-19 Vaccine for 6-11-Year-Olds
MT
05/13
Swissmedic OKs Moderna's COVID-19 Jab For Children Aged Six To 11 Years
MT
05/13
N.Korea gets offers of aid to fight COVID as it lacks vaccines
RE
05/13
Switzerland authorizes Moderna's COVID vaccine for 6-11 year olds
RE
05/12
MARKETSCREENERS WORLD PRESS REVIEW
: May 12, 2022
05/12
Moderna CFO exits firm a day after taking charge as probe launched
AQ
05/11
Moderna completes FDA submission for use of COVID shot in adolescents, kids
RE
More news
News in other languages on MODERNA, INC.
04:20a
Valneva-Aktie bricht ein - EU will Covid-19-Vakzin-Kontrakt kündigen
04:04a
CORONAVIRUS
: préavis de rupture du contrat européen avec Valneva
05/13
BOURSE ZURICH
: retour dans le vert pour la dernière séance de la semaine
05/13
COREA DEL SUD
: vuole inviare vaccini anti-Covid a Pyongyang
05/13
MISE À JOUR SECTORIELLE
: Les actions du secteur de la santé progressent vendredi avant le..
05/13
L'organisme de réglementation médicale suisse approuve le vaccin Covid-19 de Moderna po..
05/13
Swissmedic autorise le COVID-19 Jab de Moderna pour les enfants âgés de 6 à 11 ans
05/13
BOURSE ZURICH
: le SMI consolide ses gains à l'approche de la mi-journée
05/13
Swissmedic lässt Moderna-Impfstoff für Kinder zwischen 6 und 11 Jahren zu
05/12
GENEURO
: augmentation de capital de 7,7 millions d'euros
More news
Analyst Recommendations on MODERNA, INC.
04/13
ANALYST RECOMMENDATIONS
: CarMax, Boeing, JetBlue, Medtronic, PepsiCo...
04/12
Morgan Stanley Adjusts Moderna Price Target to $217 From $205, Maintains Equal Weight R..
MT
03/25
SVB Leerink Adjusts Moderna's Price Target to $80 from $81, Keeps Underperform Rating
MT
03/07
Deutsche Bank Adjusts Moderna's Price Target to $155 From $175, Maintains Hold Rating
MT
02/28
Morgan Stanley Adjusts Moderna Price Target to $205 From $213, Maintains Equalweight Ra..
MT
More recommendations
Press releases
05/13
MODERNA, INC. Change in Directors or Principal Officers, Financial Statements and Exhi..
AQ
05/13
KHF Welcomes the African Medicines Agency Treaty Cabinet Approval
AQ
05/12
Moderna CFO exits firm a day after taking charge as probe launched
AQ
05/11
MODERNA, INC.
: Change in Directors or Principal Officers (form 8-K)
AQ
05/05
FDA restricts J&J's COVID-19 vaccine due to blood clot risk
AQ
More press releases
Powered by Scoopnest.com
Analysis
Pfizer's $11.6 billion Biohaven buy could spark more biotech deals
More Must read
Stock Trading Strategies
TRADING
A support level that should be taken advantage of
More Stock Trading Analysis
Official Publications
05/04
Press Release
05/04
SEC Filing 10Q-1
05/04
1st quarter results
05/04
SEC Filing 8K
04/28
Press Release
04/27
Nomination
More Official Publications
Upcoming event on MODERNA, INC.
08/10/22
Interim 2022 Earnings Release (Projected)
Company calendar
Upcoming sector events
07/26/22
IQVIA HOLDINGS INC.
: Interim 2022 Earnings Release (Projected)
07/27/22
LONZA GROUP AG
: Interim 2022 Earnings Release (Projected)
07/28/22
SEAGEN INC.
: Interim 2022 Earnings Release (Projected)
10/26/22
IQVIA HOLDINGS INC.
: Q3 2022 Earnings Release (Projected)
More events
Sector
Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research
Slave